FeesSafety
Pluang+

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Company Fundamentals
11 Nov 2026, 04:00 WIB
Na
View Source
Bullish
Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans to add independent directors as it moves toward SEC reporting status. It aims to complete an audit and file a registration statement within six months, marking the first step toward listing on a national securities exchange. The company also changed its name to Scopien Technologies Inc. and is preparing for a new trading symbol, signaling a strategic shift to expand its AI business.

Cannabis Strategic Ventures' change of control with Scopien Technologies provides context for readers following related corporate shifts. For readers following Technology-sector US stocks on Pluang, here is the market snapshot as of Nov 11, 2026 04:02 WIB: out of 150 priced stocks, 60 rose and 89 fell. Notable movers include VNET Group Inc at USD 3.00 with a 1-day change of -8.40% and 100% sell order activity, AXT Inc at USD 39.34 down 8.32% with 56% buy activity, and Zeta Global Holdings Corp at USD 35.05 up 8.11% with 63% buy activity.

More News

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
17 minutes ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
17 minutes ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
2 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
2 hours ago
Pepeto presale nears sellout with $11.29M raised as XRP price targets $27 amid recent dip.

Pepeto presale nears sellout with $11.29M raised as XRP price targets $27 amid recent dip.

Pepeto's crypto presale is close to selling out, having raised $11.29 million with over 43,000 holders, driven by its fee-free trading platform and AI contract checks. Meanwhile, XRP's price has dropped to $1.11, down 72% from its peak, but analysts ...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App